High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma
✍ Scribed by M. Engelhardt; R. Zeiser; G. Ihorst; J. Finke; C. I. Müller
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 512 KB
- Volume
- 133
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
vomiting after high dose chemotherapy with autologous peripheral stem cell transplantation (PSCT) in the treatment of high risk breast carcinoma patients. 1 Division of Digestive Diseases, Department of METHODS. Patients with high risk breast carcinoma were conditioned with high
## Abstract A systematic review was performed to determine whether first‐line dose‐intensive chemotherapy supported by growth factor or autologous bone marrow/stem cell transplantation improves response rate, time‐to‐disease progression, or survival compared with standard‐dose chemotherapy in patie